23/02/2026
Barbacid’s research in Spain and the advance against pancreatic cancer
The challenge of financing the next phase. 🧐
Although the preclinical progress is remarkable, moving towards human trials requires considerable funding . Barbacid and his team have estimated that they could need around 30 million euros to advance to clinical trials and regulatory studies.
More information in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/barbacids-research-and-the-advance-against-pancreatic-cancer/